The Cellular Organisation Of Interneurones In Human Retina
Funder
National Health and Medical Research Council
Funding Amount
$526,454.00
Summary
Our goal is to determine the numbers and types of nerve cells in the human retina: the part of the eye where visual processing starts. This data will serve as a baseline against which effects of visual disease can be measured.
We will investigate changes in the retina secondary to disease process and try and modify them to allow a longer time frame for intervention. These changes (remodelling) are detrimental to visual function and the effectiveness of measures aimed at restoring vision, eg, bionic eye.
Role Of Dendritic Information Processing In Visual Circuit Computations
Funder
National Health and Medical Research Council
Funding Amount
$895,244.00
Summary
Vision is the primary sensory modality in man, and its disturbance carries an enormous socio-economic burden. The dynamic operations of the neuronal assemblies that underlie vision are poorly understood, partly because of an incomplete description of the computational properties of visual neuronal circuits. The aims of the application are to mechanistically dissect defined computational operations of visual neural circuits using advanced electrophysiological and optical recording techniques.
Brain Pathways Serving Conscious And Sub-conscious Vision
Funder
National Health and Medical Research Council
Funding Amount
$571,444.00
Summary
In humans and other primates the visual system comprises evolutionary new pathways (called magnocellular or M, and parvocellular or P) superimposed on evolutionary old pathways (called koniocellular or K). These parallel pathways carry visual information from the retina, through a brain centre in the thalamus called lateral geniculate nucleus (LGN), to the cerebral neocortex. Our aim is to study the role of the K pathway in visual processing.
The Role Of Gliosis In Advanced Retinal Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$457,785.00
Summary
The development of treatments that restore vision assumes that the output neurons of the retina remain intact. Yet, there is now considerable evidence that the neurons that signal from the retina to the brain are altered in those that have degenerative diseases of the retina. Here, we will examine the cause of these cellular changes in an animal model and seek to prevent the loss of output neurons. This information is crucial for the development of treatments that seeks to restore vision.
Understanding the structure of the human retina is important for understanding normal visual function. The goal of this study is to supply data on the distribution, density and connectivity of nerve cells in the human retina. Our study will provide a foundation for areas of clinical investigation of the human retina.
The Use Of MicroRNA As Novel Therapeutic Targets For Reducing Retinal Inflammation And Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$349,076.00
Summary
Age-Related Macular Degeneration (AMD) is the most common cause of blindness in Australia. We aim to investigate a new class of potential therapeutics, microRNA which are involved in the regulation of many biological processes, including inflammation. A greater understanding of these miRNA will enable discovery of novel therapeutic targets for inflammatory diseases like AMD, and will have further reaching applications in other inflammatory disease such as Alzheimer’s and Parkinson’s.
Abnormalities in cells at the back of the eye called photoreceptors are associated with at least 50% of all cases of blindness in this country.This project will examine a novel mechanism of photoreceptor death. In particular, whether abnormalties in support cells at the back of the eye cause photoreceptors to lose contact with their nutrient source and die.
Glaucoma is a progressive, poorly understood blinding disease with limited treatment options. It is characterised by the death of the nerve cells in the eye whose fibres form the optic nerve. Results obtained in the current proposal will lead to a better understanding of key features of the early stages of the disease and, additionally, will explore the potential of a novel therapeutic approach based on regeneration of damaged nerve fibres within the optic nerve.
Age-related macular degeneration, involves the progressive loss of light sensitive cells from the retina, and is a major cause of loss of vision, and quality of life, in people over 60. Activation of immune mechanisms have been implicated in the disease, but it is not understood, why the immune system attacks vision cells. This study looks at the mechanisms of the activation of immune cells and will test treatment strategies to minimize immune activation, and thereby prevent blindness.